(Q38079287)

28 August 2017

1 reference

title

Thrombin inhibitors: surgical considerations and pharmacology (English)

1 reference

28 August 2017

1 reference

Omar Breik

1

1 reference

PubMed ID

23384088

28 August 2017

Rami Tadros

series ordinal

2

1 reference

PubMed ID

23384088

28 August 2017

Peter Devitt

series ordinal

3

1 reference

28 August 2017

6 February 2013

1 reference

28 August 2017

ANZ Journal of Surgery

1 reference

28 August 2017

83

1 reference

28 August 2017

215-221

1 reference

28 August 2017

4

1 reference

A once-daily, oral, direct Factor Xa inhibitor, rivaroxaban (BAY 59-7939), for thromboprophylaxis after total hip replacement

28 August 2017

1 reference

Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty

21 January 2018

1 reference

Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty

21 January 2018

1 reference

Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial

21 January 2018

1 reference

Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery.

21 January 2018

1 reference

Structure-based design of novel potent nonpeptide thrombin inhibitors

21 January 2018

1 reference

Platelet activation with unfractionated heparin at therapeutic concentrations and comparisons with a low-molecular-weight heparin and with a direct thrombin inhibitor.

21 January 2018

1 reference

Ximelagatran/Melagatran: a review of its use in the prevention of venous thromboembolism in orthopaedic surgery

21 January 2018

1 reference

Trials and tribulations of non-inferiority: the ximelagatran experience

21 January 2018

1 reference

Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate

21 January 2018

1 reference

Influence of renal impairment on the pharmacokinetics and pharmacodynamics of oral dabigatran etexilate: an open-label, parallel-group, single-centre study

21 January 2018

1 reference

The metabolism and disposition of the oral direct thrombin inhibitor, dabigatran, in humans

21 January 2018

1 reference

Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity

21 January 2018

1 reference

Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial.

21 January 2018

1 reference

Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial.

21 January 2018

1 reference

Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery

21 January 2018

1 reference

Dabigatran versus warfarin in the treatment of acute venous thromboembolism

21 January 2018

1 reference

Dabigatran versus warfarin in patients with atrial fibrillation

21 January 2018

1 reference

21 January 2018

Noninferiority trials

1 reference

Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial

21 January 2018

1 reference

New anticoagulants - promising and failed developments.

21 January 2018

1 reference

Pharmacokinetic profile of the oral direct thrombin inhibitor dabigatran etexilate in healthy volunteers and patients undergoing total hip replacement

21 January 2018

1 reference

Using the HEMOCLOT direct thrombin inhibitor assay to determine plasma concentrations of dabigatran

21 January 2018

1 reference

Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects

21 January 2018

1 reference

Platelet activity of high-dose factor VIIa is independent of tissue factor

21 January 2018

1 reference

Effects of agents, used to treat bleeding disorders, on bleeding time prolonged by a very high dose of a direct thrombin inhibitor in anesthesized rats and rabbits

21 January 2018

1 reference

Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial

21 January 2018

1 reference

Current concepts of the management of dental extractions for patients taking warfarin

21 January 2018

1 reference

Safe use of hemodialysis for dabigatran removal before cardiac surgery

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/ANS.12078

1 reference

28 August 2017

1 reference

PubMed ID

23384088